THE Therapeutic Goods Administration has opened a public consultation on its current good manufacturing practice (GMP) fees and charges.
Proposed new arrangements aim to improve the accuracy and transparency of cost recovery arrangements, and "address a significant under-recovery over the past four financial years".
The consultation closes on 05 Mar 2018 - see www.tga.gov.au
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Feb 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Feb 18
